First Time Loading...

Pfizer Inc
NYSE:PFE

Watchlist Manager
Pfizer Inc Logo
Pfizer Inc
NYSE:PFE
Watchlist
Price: 27.79 USD 0.04%
Updated: Mar 28, 2024

Wall Street
Price Targets

PFE Price Targets Summary
Pfizer Inc

Wall Street analysts forecast PFE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PFE is 32.86 USD with a low forecast of 26.26 USD and a high forecast of 52.5 USD.

Lowest
Price Target
26.26 USD
6% Downside
Average
Price Target
32.86 USD
18% Upside
Highest
Price Target
52.5 USD
89% Upside

PFE Last Price Targets
Pfizer Inc

The latest public price target was made on Feb 14, 2024 by Louise Chen from Cantor Fitzgerald , who expects PFE stock to rise by 62% over the next 12 months. You can read more about this price target by viewing the article on Benzinga.

Analyst Price Target Date Article
Louise Chen
Cantor Fitzgerald
45 USD
Upside 62%
1 month ago
Feb 14, 2024
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
Benzinga
Thomas Yeh
Morgan Stanley
20 USD
Downside 28%
3 months ago
Dec 14, 2023
Harmonic To Rally Over 80%? Here Are 10 Top Analyst Forecasts For Thursday
Benzinga
Terence Flynn
Morgan Stanley
37 USD
Upside 33%
4 months ago
Nov 27, 2023
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
Benzinga
Unknown Analyst
Morgan Stanley
45 USD
Upside 62%
1 year ago
Feb 1, 2023
Morgan Stanley Maintains Equal-Weight on Pfizer, Lowers Price Target to $45
Benzinga
Unknown Analyst
Barclays
44 USD
Upside 58%
1 year ago
Feb 1, 2023
Barclays Maintains Equal-Weight on Pfizer, Lowers Price Target to $44
Benzinga
Unknown Analyst
Credit Suisse
50 USD
Upside 80%
1 year ago
Feb 1, 2023
Credit Suisse Maintains Outperform on Pfizer, Lowers Price Target to $50
Benzinga
Unknown Analyst
Leerink Partners
48 USD
Upside 73%
1 year ago
Feb 1, 2023
SVB Leerink Maintains Market Perform on Pfizer, Lowers Price Target to $48
Benzinga
Unknown Analyst
Atlantic Equities
46 USD
Upside 66%
1 year ago
Feb 1, 2023
Atlantic Equities Maintains Neutral on Pfizer, Lowers Price Target to $46
Benzinga
Show More Price Targets
Show Less Price Targets
Louise Chen
Cantor Fitzgerald
Price Target 45 USD
Upside/Downside 62%
View Source
Thomas Yeh
Morgan Stanley
Price Target 20 USD
Upside/Downside 28%
View Source
Terence Flynn
Morgan Stanley
Price Target 37 USD
Upside/Downside 33%
View Source
Unknown Analyst
Morgan Stanley
Price Target 45 USD
Upside/Downside 62%
View Source
Unknown Analyst
Barclays
Price Target 44 USD
Upside/Downside 58%
View Source
Unknown Analyst
Credit Suisse
Price Target 50 USD
Upside/Downside 80%
View Source
Unknown Analyst
Leerink Partners
Price Target 48 USD
Upside/Downside 73%
View Source
Unknown Analyst
Atlantic Equities
Price Target 46 USD
Upside/Downside 66%
View Source
Show More Price Targets
Show Less Price Targets
Pfizer Inc Competitors:
Price Targets
600085
Beijing Tongrentang Co Ltd
50% Upside
524731
Jenburkt Pharmaceuticals Ltd
25% Downside
ROVI
Laboratorios Farmaceuticos ROVI SA
8% Downside
001630
Chongkundang Holdings Corp
1% Upside
SAN
Sanofi SA
17% Upside
214370
Caregen Co Ltd
124% Upside
300723
Yipinhong Pharmaceutical Co Ltd
40% Upside
NATCOPHARM
Natco Pharma Ltd
8% Downside

Revenue
Forecast

Revenue Estimate
Pfizer Inc

For the last 8 years the compound annual growth rate for Pfizer Inc's revenue is 2%. The projected CAGR for the next 3 years is 3%.

2%
Past Growth
3%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Pfizer Inc

For the last 8 years the compound annual growth rate for Pfizer Inc's operating income is -1%. The projected CAGR for the next 3 years is 16%.

-1%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-22%
Average Miss

Net Income
Forecast

Net Income Estimate
Pfizer Inc

For the last 8 years the compound annual growth rate for Pfizer Inc's net income is -14%. The projected CAGR for the next 3 years is 98%.

-14%
Past Growth
98%
Estimated Growth
Estimates Accuracy
-35%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PFE's stock price target?
Price Target
32.86 USD

According to Wall Street analysts, the average 1-year price target for PFE is 32.86 USD with a low forecast of 26.26 USD and a high forecast of 52.5 USD.

What is Pfizer Inc's Revenue forecast?
Projected CAGR
3%

For the last 8 years the compound annual growth rate for Pfizer Inc's revenue is 2%. The projected CAGR for the next 3 years is 3%.

What is Pfizer Inc's Operating Income forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Pfizer Inc's operating income is -1%. The projected CAGR for the next 3 years is 16%.

What is Pfizer Inc's Net Income forecast?
Projected CAGR
98%

For the last 8 years the compound annual growth rate for Pfizer Inc's net income is -14%. The projected CAGR for the next 3 years is 98%.